Genetic Polymorphisms by Deletion in Genes That Encode for Glutathione S-Transferases Are Associated with Nicotine Dependence and Tobacco Use-Related Medical Disorders

Luiz Gustavo Piccoli de Melo,Heber Odebrecht Vargas,Marcia Regina Pizzo de Castro,Maria Angelica Ehara Watanabe,Roberta Losi Guembarovski,Michael Maes,Sandra Odebrecht Vargas Nunes
2015-01-01
Neuroendocrinology letters
Abstract:OBJECTIVE We examine the relationship between nicotine dependence (ND) and ND-related medical disease and polymorphisms by deletion in genes that encode glutathione S-transferases (GSTs), e.g. GSTM1 and GSTT1. Individuals with homozygous gene deletions show deficiencies in GSTs enzyme activities impairing detoxification. METHODS This study comprised 182 tobacco users and 182 controls (neversmokers). GSTM1 and GSTT1 polymorphisms were assessed using a Multiplex- PCR based protocol. RESULTS Logistic regression analyses showed a significant association between ND and the GSTM1 and GSTT1 null genotypes. There were no significant associations between GSTT1, GSTM1 and GSTT1/M1 genetic variants and the Fagerström test for ND, age at onset, smoking cessation or a family history of ND. Patients with ND had increased rates of a family ND history and an increased prevalence of cardiovascular disease, hypertension, and lung disease. The null genotypes were associated with hypertension (i.e. GSTT1 × ND interaction), diabetes type 2 (i.e. GSTM1 × GSTT1 interaction), lung disease (i.e. GSTM1 × ND interaction) and cancer (i.e. GSTT1). The results show that GST null genotypes may confer protection against ND while they increase risk towards ND-related medical disorders.
What problem does this paper attempt to address?